Aptol Pharma ApS

CVR 39308967 · Private limited company (ApS) · In bankruptcy

Aptol Pharma ApS is a Private limited company (ApS), founded on , based in København SV. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Aptol Pharma ApS went bankrupt on – 8.2 years after it was founded. 7 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2024) shows equity of DKK -140k and a net result of DKK -131k.

Bankruptcy

Bankruptcy date
Status
In bankruptcy proceedings
Age at bankruptcy
8.2 years

Company details

CVR number
39308967
Status
In bankruptcy
Company type
Private limited company (ApS)
Founded
Address
c/o Kira Astakhova, Thad Jones Vej 6, st. th
2450 København SV
Municipality
København
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 53k
Auditor
Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab
Audit opted out
Yes

Warning signs

Annual reports filed late1 of 7
Missing annual reportNo
Negative equityYes
Equity ratio-290.3%
Current ratio26%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address2
Going-concern uncertaintyYes

Financials and key figures

Financial year20242023
Gross profitDKK 2,442DKK 414k
Net profitDKK -131kDKK 308k
EquityDKK -140kDKK -9,047
Total assetsDKK 48kDKK 163k
CashDKK 28k–
Short-term debtDKK 189k–
Tax owedDKK 36k–
Avg. employees1–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2024 – 31 Dec 202429
1 Jan 2023 – 31 Dec 202329
1 Jan 2022 – 31 Dec 2022186 Late
1 Jan 2021 – 31 Dec 20211
1 Jan 2020 – 31 Dec 20201
1 Jan 2019 – 31 Dec 20191
5 Feb 2018 – 31 Dec 20182

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOKira Gerber Petersen
BoardKira Gerber Petersen
BoardKira Gerber Petersen
BoardAnders Dyhr Dombernowsky-Toft
BoardPeter Andreas Nicolai Reumert Wagtmann
BoardMads Hartvig Clausen
BoardMads Hartvig Clausen
Owner (15%)Tue Wenzel KragstrupCurrent
Owner (15%)MDZ Solutions OÜCurrent
Owner (33%)KGAA Holding ApSCurrent
Owner (10%)Peter Andreas Nicolai Reumert WagtmannCurrent
Owner (10%)ADT HOLDING ApSCurrent
Owner (90%)Kira Gerber Petersen
Owner (20%)MDZ Solutions OÜ
Owner (0%)2200 HOLDING ApS
Owner (33%)Kira Gerber Petersen
Owner (20%)Tue Wenzel Kragstrup
Owner (20%)2200 HOLDING ApS
Owner (15%)2200 HOLDING ApS
FounderKira Gerber PetersenCurrent

The CEOs' other companies

Kira Gerber Petersen – 1 other companies, of which 1 bankrupt

Address history (1 moves)

c/o Kira Astakhova, Thad Jones Vej 6, st. th, 2450 København SV
c/o Kira Astakhova, Thad Jones Vej 6, st. tv, 2450 København SV

Former names

Aptol Pharma ApS – now
IBIO TECH ApS –
Integrated biomedical technologies ApS –

Other companies at the same address

Similar companies in København

Questions and answers about Aptol Pharma ApS

Has Aptol Pharma ApS gone bankrupt?

Yes. Aptol Pharma ApS went bankrupt on 28 April 2026.

Who is the auditor of Aptol Pharma ApS?

Aptol Pharma ApS most recently used Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab.

When was Aptol Pharma ApS founded?

Aptol Pharma ApS was founded on 5 February 2018.

What is the equity of Aptol Pharma ApS?

Equity was DKK -140k according to the annual report for the period ending 31 December 2024.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.